Q4 2024 Earnings Call Transcript March 27, 2025 ADC Therapeutics SA beats earnings expectations. Reported EPS is $-0.29, ...

Agree Realty's disciplined investment strategy and robust balance sheet, with no major debt until 2028. Read why ADC stock is ...

BioAtla is extending its runway beyond key clinical readouts in 1H 2026 by restructuring and realigning resources, which ...

MGC026, which is a TOP1i-based ADC, is undergoing a phase 1 dose-escalation study in patients with advanced solid tumors. The ...

The ODT-ADS-7B64G-3 is an ultra-high-bandwidth time-interleaved ADC designed in a 3nm CMOS process. This 7-bit, 64GSPS ADC supports ac-coupled input signals up to Nyquist and features a full-scale ...

The ADC core consist of internal DAC, bias, sample and hold circuit, analog voltage comparator. The ADC requires 3.0...3.6 V analog supply and 0.9...1.1 V digital supply voltage, there are standby ...

located in 49 states and containing approximately 47.2 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol "ADC".

After hours: March 26 at 4:07:01 PM EDT Loading Chart for ADC ...

Taal’s lawsuit, filed with fellow Cornell doctoral student Sriram Parasuram and Mukoma Wa Ngũgĩ, a Cornell literature ...

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer ...

(NASDAQ: FGEN) today reported financial results for the fourth quarter and full year 2024 and provided an update on the company’s recent developments. “We entered 2025 optimistic about our future, ...

A key pillar to this enhancement is load balancing and intelligent traffic management in the form of Application Delivery ...